|
1
|
Liu P, Gan W, Guo C, Xie A, Gao D, Guo J,
Zhang J, Willis N, Su A, Asara JM, et al: Akt-mediated
phosphorylation of XLF impairs non-homologous end-joining DNA
repair. Mol Cell. 57:648–661. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang S, Matsunaga S, Lin YF, Sishc B,
Shang Z, Sui J, Shih HY, Zhao Y, Foreman O, Story MD, et al:
Spontaneous tumor development in bone marrow-rescued DNA-PKcs
(3A/3A) mice due to dysfunction of telomere leading strand
deprotection. Oncogene. 35:3909–3918. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kurimasa A, Ouyang H, Dong LJ, Wang S, Li
X, Cordon-Cardo C, Chen DJ and Li GC: Catalytic subunit of
DNA-dependent protein kinase: Impact on lymphocyte development and
tumorigenesis. Proc Natl Acad Sci USA. 96:pp. 1403–1408. 1999;
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang S, Guo M, Ouyang H, Li X,
Cordon-Cardo C, Kurimasa A, Chen DJ, Fuks Z, Ling CC and Li GC: The
catalytic subunit of DNA-dependent protein kinase selectively
regulates p53-dependent apoptosis but not cell-cycle arrest. Proc
Natl Acad Sci USA. 97:pp. 1584–1588. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chitnis MM, Lodhia KA, Aleksic T, Gao S,
Protheroe AS and Macaulay VM: IGF-1R inhibition enhances
radiosensitivity and delays double-strand break repair by both
non-homologous end-joining and homologous recombination. Oncogene.
33:5262–5273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee SH and Kim CH: DNA-dependent protein
kinase complex: A multifunctional protein in DNA repair and damage
checkpoint. Mol Cells. 13:159–166. 2002.PubMed/NCBI
|
|
7
|
Bunting SF and Nussenzweig A: End-joining,
translocations and cancer. Nat Rev Cancer. 13:443–454. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Branzei D and Foiani M: Regulation of DNA
repair throughout the cell cycle. Nat Rev Mol Cell Biol. 9:297–308.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Li GC, Iliakis G and Wang Y: Ku
affects the CHK1-dependent G (2) checkpoint after ionizing
radiation. Cancer Res. 62:6031–6034. 2002.PubMed/NCBI
|
|
10
|
Shang ZF, Huang B, Xu QZ, Zhang SM, Fan R,
Liu XD, Wang Y and Zhou PK: Inactivation of DNA-dependent protein
kinase leads to spindle disruption and mitotic catastrophe with
attenuated checkpoint protein 2 Phosphorylation in response to DNA
damage. Cancer Res. 70:3657–3666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weber AM and Ryan AJ: ATM and ATR as
therapeutic targets in cancer. Pharmacol Ther. 149:124–138. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Curtin NJ: DNA repair dysregulation from
cancer driver to therapeutic target. Nat Rev Cancer. 12:801–817.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bouwman P and Jonkers J: The effects of
deregulated DNA damage signalling on cancer chemotherapy response
and resistance. Nat Rev Cancer. 12:587–598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bozulic L, Surucu B, Hynx D and Hemmings
BA: PKBalpha/Akt1 acts downstream of DNA-PK in the DNA
double-strand break response and promotes survival. Mol Cell.
30:203–213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Y, Thomas HD, Batey MA, Cowell IG,
Richardson CJ, Griffin RJ, Calvert AH, Newell DR, Smith GC and
Curtin NJ: Preclinical evaluation of a potent novel DNA-dependent
protein kinase inhibitor NU7441. Cancer Res. 66:5354–5362. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu L, Tumati V, Tseng SF, Hsu FM, Kim DN,
Hong D, Hsieh JT, Jacobs C, Kapur P and Saha D: DAB2IP regulates
autophagy in prostate cancer in response to combined treatment of
radiation and a DNA-PKcs inhibitor. Neoplasia. 14:1203–1212. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tavecchio M, Munck JM, Cano C, Newell DR
and Curtin NJ: Further characterisation of the cellular activity of
the DNA-PK inhibitor, NU7441, reveals potential cross-talk with
homologous recombination. Cancer Chemother Pharmacol. 69:155–164.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Javvadi P, Makino H, Das AK, Lin YF, Chen
DJ, Chen BP and Nirodi CS: Threonine 2609 phosphorylation of the
DNA-dependent protein kinase is a critical prerequisite for
epidermal growth factor receptor-mediated radiation resistance. Mol
Cancer Res. 10:1359–1368. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ciszewski WM, Tavecchio M, Dastych J and
Curtin NJ: DNA-PK inhibition by NU7441 sensitizes breast cancer
cells to ionizing radiation and doxorubicin. Breast Cancer Res
Treat. 143:47–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tichy A, Durisova K, Salovska B, Pejchal
J, Zarybnicka L, Vavrova J, Dye NA and Sinkorova Z:
Radio-sensitization of human leukaemic MOLT-4 cells by
DNA-dependent protein kinase inhibitor, NU7441. Radiat Environ
Biophys. 53:83–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cornell L, Munck JM, Alsinet C, Villanueva
A, Ogle L, Willoughby CE, Televantou D, Thomas HD, Jackson J, Burt
AD, et al: DNA-PK-A candidate driver of hepatocarcinogenesis and
tissue biomarker that predicts response to treatment and survival.
Clin Cancer Res. 21:925–933. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu L, Shang ZF, Hsu FM, Zhang Z, Tumati V,
Lin YF, Chen BP and Saha D: NSCLC cells demonstrate differential
mode of cell death in response to the combined treatment of
radiation and a DNA-PKcs inhibitor. Oncotarget. 6:3848–3860. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chua MLK, Wee JTS, Hui EP and Chan ATC:
Nasopharyngeal carcinoma. Lancet. 387:1012–1024. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ouyang H, Nussenzweig A, Kurimasa A,
Soares VC, Li X, Cordon-Cardo C, Li W, Cheong N, Nussenzweig M,
Iliakis G, et al: Ku70 is required for DNA repair but not for T
cell antigen receptor gene recombination in vivo. J Exp Med.
186:921–929. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dong J, Zhang T, Ren Y, Wang Z, Ling CC,
He F, Li GC, Wang C and Wen B: Inhibiting DNA-PKcs in a
non-homologous end-joining pathway in response to DNA double-strand
breaks. Oncotarget. 8:22662–22673. 2017.PubMed/NCBI
|
|
26
|
Lu QP, Chen WD, Peng JR, Xu YD, Cai Q,
Feng GK, Ding K, Zhu XF and Guan Z: Antitumor activity of 7RH, a
discoidin domain receptor 1 inhibitor, alone or in combination with
dasatinib exhibits antitumor effects in nasopharyngeal carcinoma
cells. Oncol Lett. 12:3598–3608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q,
Luo X, Chen Y, Deng X, Liang Z, et al: miR-3188 regulates
nasopharyngeal carcinoma proliferation and chemosensitivity through
a FOXO1-modulated positive feedback loop with
mTOR-p-PI3K/AKT-c-JUN. Nat Commun. 7:113092016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wen B, Deutsch E, Marangoni E, Frascona V,
Maggiorella L, Abdulkarim B, Chavaudra N and Bourhis J: Tyrphostin
AG 1024 modulates radiosensitivity in human breast cancer cells. Br
J Cancer. 85:2017–2021. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kataoka Y, Bindokas VP, Duggan RC, Murley
JS and Grdina DJ: Flow cytometric analysis of phosphorylated
histone H2AX following exposure to ionizing radiation in human
microvascular endothelial cells. J Radiat Res (Tokyo). 47:245–257.
2006. View Article : Google Scholar
|
|
30
|
Cuneo KC, Morgan MA, Davis MA, Parcels LA,
Parcels J, Karnak D, Ryan C, Liu N, Maybaum J and Lawrence TS: Wee1
kinase inhibitor AZD1775 radiosensitizes hepatocellular carcinoma
regardless of TP53 mutational status through induction of
replication stress. Int J Radiat Oncol Biol Phys. 95:782–790. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bonner WM, Redon CE, Dickey JS, Nakamura
AJ, Sedelnikova OA, Solier S and Pommier Y: GammaH2AX and cancer.
Nat Rev Cancer. 8:957–967. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sulli G, Di Micco R and d'Adda di Fagagna
F: Crosstalk between chromatin state and DNA damage response in
cellular senescence and cancer. Nat Rev Cancer. 12:709–720. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou XY, Wang X, Wang H, Chen DJ, Li GC,
Iliakis G and Wang Y: Ku affects the ATM-dependent S phase
checkpoint following ionizing radiation. Oncogene. 21:6377–6381.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Morgan MA and Lawrence TS: Molecular
pathways: Overcoming radiation resistance by targeting DNA damage
response pathways. Clin Cancer Res. 21:2898–2904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nussenzweig A, Chen C, da Costa Soares V,
Sanchez M, Sokol K, Nussenzweig MC and Li GC: Requirement for Ku80
in growth and immunoglobulin V (D)J recombination. Nature.
382:551–555. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li GC, He F, Shao X, Urano M, Shen L, Kim
D, Borrelli M, Leibel SA, Gutin PH and Ling CC: Adenovirus-mediated
heat-activated antisense Ku70 expression radiosensitizes tumor
cells in vitro and in vivo. Cancer Res. 63:3268–3274.
2003.PubMed/NCBI
|
|
37
|
He F, Li L, Kim D, Wen B, Deng X, Gutin
PH, Ling CC and Li GC: Adenovirus-mediated expression of a dominant
negative Ku70 fragment radiosensitizes human tumor cells under
aerobic and hypoxic conditions. Cancer Res. 67:634–642. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peng Y, Zhang Q, Nagasawa H, Okayasu R,
Liber HL and Bedford JS: Silencing expression of the catalytic
subunit of DNA-dependent protein kinase by small interfering RNA
sensitizes human cells for radiation-induced chromosome damage,
cell killing, and mutation. Cancer Res. 62:6400–6404.
2002.PubMed/NCBI
|
|
39
|
An J, Xu QZ, Sui JL, Bai B and Zhou PK:
Downregulation of c-myc protein by siRNA-mediated silencing of
DNA-PKcs in HeLa cells. Int J Cancer. 117:531–537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Toulany M, Kehlbach R, Florczak U, Sak A,
Wang S, Chen J, Lobrich M and Rodemann HP: Targeting of AKT1
enhances radiation toxicity of human tumor cells by inhibiting
DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther.
7:1772–1781. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Goodwin JF and Knudsen KE: Beyond DNA
repair: DNA-PK function in cancer. Cancer Discov. 4:1126–1139.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie
FY, Sun Y, Chen XZ, Li JG, Zhu XD, et al: Induction chemotherapy
plus concurrent chemoradiotherapy versus concurrent
chemoradiotherapy alone in locoregionally advanced nasopharyngeal
carcinoma: A phase 3, multicentre, randomised controlled trial.
Lancet Oncol. 17:1509–1520. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ren Y, Zhao Q, Liu H, Huang Y, Wang Z, Cao
X, Teh BS and Wen B: 3D-image-guided HDR-brachytherapy versus 2D
HDR - brachytherapy after external beam radiotherapy for early
T-stage nasopharyngeal carcinoma. BMC Cancer. 14:8942014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang C, Huang P, Guo L, Wang Z, Zhang T,
Dong J, Shi J, Li Y, Guo X, Cao K, et al: Prognostic analysis in
patients with metastatic nasopharyngeal carcinoma at initial
diagnosis. Jacobs J Radiat Oncol. 1:102014.
|
|
45
|
Lee SW, Cho KJ, Park JH, Kim SY, Nam SY,
Lee BJ, Kim SB, Choi SH, Kim JH, Ahn SD, et al: Expressions of Ku70
and DNA-PKcs as prognostic indicators of local control in
nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys.
62:1451–1457. 2005. View Article : Google Scholar : PubMed/NCBI
|
